Insight 2811 Inc’s Boston Scientific BSX Stock Holding History

Insight 2811 Inc’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-29,331	Closed	-$685K	–	91
2016 Q2	$685K	Sell	29,331 -3,134	-10%	-$67.8K	0.26%	62
2016 Q1	$611K	Sell	32,465 -1,920	-6%	-$33.7K	0.24%	65
2015 Q4	$634K	Hold	34,385	–	–	0.3%	60
2015 Q3	$564K	Sell	34,385 -60	-0.2%	-$1.03K	0.33%	60
2015 Q2	$610K	Sell	34,445 -190	-0.5%	-$3.4K	0.29%	63
2015 Q1	$615K	Buy	+34,635	New	+$547K	0.29%	67

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Insight 2811 Inc's BSX Position: Q3 2016 in Review

Insight 2811 Inc sold out of Boston Scientific (BSX) in Q3 2016, closing a stake of 29,331 shares — an estimated $685K sold.

Insight 2811 Inc first reported a position in BSX in Q1 2015 and held it in 6 quarters. The position peaked at $685K in Q2 2016. 568 funds tracked by Wall St. Rank hold BSX as of Q3 2016.

Insight 2811 Inc reported no remaining Boston Scientific position as of Q3 2016 after selling out during the quarter.
Insight 2811 Inc sold 29,331 Boston Scientific shares in Q3 2016, an estimated $685K.
Insight 2811 Inc first reported a position in Boston Scientific in Q1 2015 and held it in 6 quarters.
Insight 2811 Inc's Boston Scientific position peaked at $685K in Q2 2016.
568 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2016.

Based on Insight 2811 Inc's 13F filing for Q3 2016, filed 25 Oct 2016.